Technology
overview
At NeuraLight, we leverage the wide evidence-based literature on eye movement abnormalities in CNS diseases, to provide a valuable assessment tool for CNS diseases.
Easy to use platform
Only requiring a brief patient assessment, our software-based platform is designed for simple integration into any clinical environment.
Objective clinical assessment
NeuraLight leverages computer vision and machine learning to capture and analyze multiple ocular measures in a single assessment.
Valuable clinical insights
Leveraging the intrinsic connection between eye movements and different brain regions, NeuraLight enables researchers to accurately measure and understand the status of CNS diseases.
PARTNERSHIPS
Partner with us to accelerate your CNS drug development
